Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Mice Don’t Menstruate: Reimagining Women’s Health Using Organ Chips with Dr. Donald Ingber

Mice Don’t Menstruate: Reimagining Women’s Health Using Organ Chips with Dr. Donald Ingber

FromInnovate and Elevate


Mice Don’t Menstruate: Reimagining Women’s Health Using Organ Chips with Dr. Donald Ingber

FromInnovate and Elevate

ratings:
Length:
28 minutes
Released:
May 7, 2024
Format:
Podcast episode

Description

In this episode, Sharon is joined by Dr. Donald Ingber, Founding Director at Wyss Institute for Biologically Inspired Engineering at Harvard University. Dr. Ingber’s commitment to following his passion has led him to countless medical and technological breakthroughs, including organ-chip technology. These incredible chips recreate the structure and function of human organs. Drugs can be administered through organ-chips so that blood impact can be monitored. Once more widely adopted, organ-chip testing will be able to replace animal testing. As Dr. Ingber shares, the results will surpass those of animal testing.The organ-chip technology already includes women’s health models and holds great promise to revolutionize this under-invested area. Because animals, namely mice, do not have menstrual cycles, their biological environments are already skewed to test any women’s health-related projects. Organ-chips are a great solution to close the data gap. Dr. Ingber shares two projects underway in partnership with the Gates Foundation: to create a cure for bacterial vaginosis and to create a non-hormonal contraceptive. Dr. Ingber highlights the importance of nurturing the business side of scientific breakthroughs so that innovations can reach patients. Twenty percent of Harvard’s intellectual property comes out of the Wyss Institute, and both funding and mentorship play crucial roles in that success metric.  Episode Outline(00:53) Meet Dr. Donald Inbger (02:11) Where Art Meets Science: Inside The Brilliant Mind of Dr. Ingber (07:08) What Is Organ-on-a-Chip Technology? (13:17) Reimaging Women’s Health with Organ-Chips(21:11) Think Outside The Box: Bringing Innovation to Life Connect with SharonConnect with Sharon on LinkedIn: Sharon KedarLearn more about Innovate and Elevate innovateandelevatepodcast.comSubscribe to Innovate and Elevate on YouTubeJoin the newsletter to receive the latest episodes in your inbox: Innovate and Elevate NewsletterConnect with Dr. IngberFollow The Wyss Institute on LinkedInLearn more about Emulate, Inc.Additional ResourcesThe Wyss Institute The Wyss-Northpond Research And Innovation Alliance First rodent found with a human-like menstrual cycleThe White House Initiative on Women's Health ResearchThis podcast is produced by the women at The Wave Editing.
Released:
May 7, 2024
Format:
Podcast episode

Titles in the series (5)

Behind every pioneering idea, method, and device is a fellow human or humans. A trailblazer who is daring enough to ask the questions that push the boundaries and make the impossible possible. Host Sharon Kedar, MBA, CFA, talks with these change agents on the Innovate and Elevate podcast. In each episode, you hear from top doctors, scientists, leaders, and innovators on how they are trailblazing within the world at large and within their own lives. As the co-founder of Northpond Ventures, a multi-billion-dollar science-driven venture capital firm, Sharon is frequently rethinking the limits of what is possible. Season one focuses on women’s health with the aim of helping women lead our healthiest lives. You’ll hear from leading experts such as Dr. Kathryn Rexrode, Division Chief, Women’s Health at Harvard’s Brigham Hospital. Tune in wherever you listen to podcasts, and please remember to follow Innovate and Elevate on Apple Podcasts or Spotify so you can be the first to know when new episodes are available. The views and opinions of the host and podcast guests are their own professional opinions and may not represent the views of Northpond Ventures.